Is Nuwellis Inc (NUWE) overvalued? · P/E 0.0, rev $8.7M
Nuwellis Inc (NUWE) is a medical devices company listed on US.
This page asks whether Nuwellis Inc (NUWE) looks expensive on cached numbers — not a short thesis.
Latest reported NUWE revenue for 2024-12-31 was $8.7M. Net income was -$11.2M. Revenue was down 1.4% from 2023-12-31 to 2024-12-31. NUWE currently screens at market cap $47.8M and trailing P/E 0.0.
NUWE currently screens at market cap $47.8M and trailing P/E 0.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NUWE 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NUWE stock page for the full model, not this heading.
Not investment advice.